Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical diagnosis and pathophysiological mechanisms of insulin allergy
2010-022246-25Phase 3Completed
- Start
- Oct 2010
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of human insulin, insulin icodec, insulin aspart, insulin glargine and insulin detemir in insulin allergy. Started Oct 2010; status: completed.
02
Drugs
human insulininsulin icodecinsulin aspartinsulin glargineinsulin detemir
03
Conditions
insulin allergy
Beyond the preview
Go deeper on 2010-022246-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022246-25.